M
MMI
Health Tech & Medtech · Pisa, Italy · Founded 2015
A developer of novel robotic solutions for unmet medical needs for microsurgery, with a teleoperated robotic platform for suturing in open surgery with wristed microinstruments MoreLess
MMI (Medical Microinstruments) is an Italian-American medtech company developing the Symani Surgical System, a teleoperated robotic platform with wristed microinstruments designed for microsurgery and supermicrosurgery on structures as small as about 0.1 mm, including lymphatic repair for lymphedema and complex reconstructive procedures. The company sells systems and related services to hospitals and surgical centres under a B2B model and continues clinical and commercial expansion in Europe and the United States. In September 2026 Angelini Ventures and the European Investment Bank co-invested €17 million in MMI as the third deal under their €150 million partnership (bringing partnership commitments to about €68.5 million), to advance Symani commercialisation and clinical development. Sources: Angelini Ventures 16 Sep 2026; EIB / GlobeNewswire; Il Sole 24 Ore.
Talent graph
MMI's talent
Source: Dealroom Talent Intelligence.
Global footprint
Where MMI has talent and traffic
team presence
Market sentiment
What the market is saying about MMI
An AI-synthesized read of the highest-engagement posts about MMI on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See MMI on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.